Ascendis Pharma Likely To Report Narrower Q3 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Ascendis Pharma A/S (NASDAQ:ASND) will release earnings results for the third quarter, after the closing bell on Wednesday, Nov. 12.Analysts expect the Hellerup, Denmark-based company to report a quarterly loss at 16 cents per share, versus a year-ago loss of $1.72 per share. The consensus estimate for Ascendis Pharma's quarterly revenue is $210.87 million, compared to $57.83 million a year earlier, according to data from Benzinga Pro.On Oct. 8, Ascendis Pharma submitted marketing authorisation application ...